Nature's Sunshine: A Herbal Engine With Digital Roots Starting To Show

Nature's Sunshine is evolving from a legacy direct seller to a digitally enabled wellness company, with record FY2025 results and strong Q1 2026 momentum. NATR's digital channel is driving North American growth, with a 98% YoY increase in digital customers and 47% digital business growth, supporting the turnaround thesis. The company boasts a robust balance sheet with $93.9 million in cash, no debt, and ongoing share buybacks, providing flexibility for investment and risk mitigation.

Seeking Alpha • Jun 8, 2026

Nature's Sunshine Products Q1 Earnings Call Highlights

Nature's Sunshine Products NASDAQ: NATR reported what management called a “very strong” start to 2026, highlighting first-quarter sales growth of 9% and adjusted EBITDA growth of 33% as the company continued to push deeper into digital channels and subscription programs while expanding its consultant base globally.

MarketBeat • May 8, 2026

Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 7, 2026

Nature's Sunshine Reports Strong First Quarter 2026 Results

Net Sales up 9% to $122.9 million, GAAP EPS up 16% to $0.29Adjusted EBITDA up 33% to $14.6 million LEHI, Utah, May 07, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Summary vs.

GlobeNewsWire • May 7, 2026

Nature's Sunshine Appoints John Hnanicek as Chief Technology Officer

Experienced Technology and Digital Transformation Leader to Advance Company's Global Digital Strategy Experienced Technology and Digital Transformation Leader to Advance Company's Global Digital Strategy

GlobeNewsWire • Apr 30, 2026

Nature's Sunshine Sets First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 5:00 p.m. ET

LEHI, Utah, April 23, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, will conduct a conference call on Thursday, May 7, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2026. The Company will report its financial results in a press release prior to the conference call.

GlobeNewsWire • Apr 23, 2026

Nature's Sunshine May Perform Better Than Expected (Rating Upgrade)

Nature's Sunshine is upgraded to Buy, driven by robust DTC growth and effective influencer marketing. NATR exceeded 2025 guidance with $480.1M revenue and $49.4M adjusted EBITDA, signaling operational outperformance. Guidance for 2026 targets $500–$515M revenue and $50–$54M EBITDA, supporting a $37.99 price target—56% above current levels.

Seeking Alpha • Mar 17, 2026

Nature's Sunshine Products: The Rally May Not Be Over

Nature's Sunshine Products delivered Q4 results and 2026 guidance that exceeded analyst expectations, driving a post-market stock surge. NATR's revenue, profits, and adjusted profits all grew year-over-year, with notable strength in Europe and North America and robust cash holdings of $93.9 million. Management guides for 2026 revenue of $500–515 million and EBITDA of $50–54 million, with a long-term vision to reach $1 billion in revenue.

Seeking Alpha • Mar 11, 2026

Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript

Seeking Alpha • Mar 10, 2026

Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results

LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025.

GlobeNewsWire • Mar 10, 2026